AKT1 and metabolic dysfunction-associated steatohepatitis: We focused primarily on the analysis of the PI3K/AKT pathway due to its well-established role in the pathogenesis of MASH, particularly in hepatocyte lipotoxicity, oxidative stress, and inflammatory responses in our current study.